FOLH1 and posterior cortical atrophy: Figure 6 shows the AUC, and the corresponding 95% CI, of each clinical variable used to predict the positivity of either 68Ga-PSMA (Figure 6a) or 68Ga-DOTA-RM2 (Figure 6b) PET/MRI in the detection of recurrent PCa.